MedTrace Logo

Phase I Pharmacokinetic Study of RX0041-2

NCT02667106 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-01-28

No results posted yet for this study

Summary

This Phase I study is to examine the systemic pharmacokinetics of RX0041-002 following acute, topical, intranasal administration to healthy male and female volunteers.

Conditions

  • Drug Reaction to Analgesic Nos

Interventions

DRUG

RX0041-2

Pharmacokinetic study

Sponsors & Collaborators

  • Pharmaceutical Project Solutions, Inc.

    lead INDUSTRY

Principal Investigators

  • Melissa L Goodhead, MSc · Clinical/Regulatory Agent

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667106 on ClinicalTrials.gov